The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Adma Biologics Inc’s stock clocked out at $19.63, up 2.19% from its previous closing price of $19.21. In other words, the price has increased by $2.19 from its previous closing price. On the day, 2.01 million shares were traded. ADMA stock price reached its highest trading level at $19.88 during the session, while it also had its lowest trading level at $19.3.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 53.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 58.45. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4640335360 and an Enterprise Value of 4665017856. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 71.05, and their Forward P/E ratio for the next fiscal year is 26.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.12 while its Price-to-Book (P/B) ratio in mrq is 20.01. Its current Enterprise Value per Revenue stands at 12.186 whereas that against EBITDA is 37.055.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is 3.18%, while the 200-Day Moving Average is calculated to be 49.34%.
Shares Statistics:
It appears that ADMA traded 4.96M shares on average per day over the past three months and 2870510 shares per day over the past ten days. A total of 236.38M shares are outstanding, with a floating share count of 228.48M. Insiders hold about 3.35% of the company’s shares, while institutions hold 88.42% stake in the company. Shares short for ADMA as of 1732838400 were 12906077 with a Short Ratio of 2.60, compared to 1730332800 on 15198480. Therefore, it implies a Short% of Shares Outstanding of 12906077 and a Short% of Float of 5.6199998.
